Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-17

FDA Approved: OXALIPLATIN — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approved a supplemental application for oxaliplatin from Qilu Pharmaceutical Co., Ltd., confirming continued availability of the generic product under the a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

SUPPL AP for OXALIPLATIN (OXALIPLATIN)